Business Context and Reporting Period
This Form 8-K is filed by Redwoods Acquisition Corp. (not Greenland Mines Ltd) on June 20, 2024. The filing addresses a pending business combination with ANEW MEDICAL, INC. (ANEW), originally agreed upon on May 30, 2023. The report discloses a material change regarding the audit of ANEW's financial statements included in the previously effective Form S-4 registration statement.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it references the attachment of financial documents:
- Audited Financial Statements: ANEW for fiscal years ended December 31, 2022, and December 31, 2023 (Exhibit 99.1).
- Unaudited Financial Statements: ANEW for the quarterly period ended March 31, 2024 (Exhibit 99.2).
These statements were re-audited or reviewed by a new auditor, Yusufali & Associates, LLC, following the disqualification of the previous auditor, B.F. Borgers, CPA PC.
Material Changes
The primary material change disclosed is the replacement of the independent auditor for ANEW MEDICAL, INC.:
- Previous Auditor: B.F. Borgers, CPA PC, who audited the 2022 financial statements included in the original Form S-4, is no longer permitted to appear or practice before the SEC.
- New Auditor: Yusufali & Associates, LLC was engaged to re-audit the 2022 statements, audit the 2023 statements, and review the unaudited Q1 2024 statements.
- Impact: The updated financial statements are now incorporated by reference into this filing to ensure compliance with SEC regulations.
Guidance, Outlook, and Risks
Outlook and Forward-Looking Statements: The filing contains forward-looking statements regarding the anticipated enterprise value, post-closing equity value, integration plans, and expected synergies of the business combination. Management emphasizes that these are not guarantees and are subject to uncertainties.
Risks and Contingencies: Key risks identified include:
- Failure to obtain stockholder approval or satisfy closing conditions.
- Redemptions by existing Redwoods stockholders affecting the transaction's capital structure.
- Operational and strategic risks related to ANEW's business.
- General economic and market factors.
Management Commentary: The company urges investors to read the Form S-4 proxy statement/prospectus for detailed information before making voting decisions.
Investor Verification Checklist
- Verify the identity of the registrant (Redwoods Acquisition Corp.) versus the target company (ANEW Medical, Inc.) to avoid confusion with unrelated entities.
- Review Exhibits 99.1 and 99.2 attached to the filing to analyze the actual financial performance of ANEW for 2022, 2023, and Q1 2024.
- Confirm the status of the Form S-4 proxy statement/prospectus and the timeline for the stockholder vote.
- Assess the potential impact of stockholder redemptions on the post-merger equity value.
- Monitor for any further updates regarding the auditor transition and the finalization of the re-audited financials.